伦瓦提尼布与辛蒂利马布加上跨动脉化学栓塞结合,作为先进肝细胞癌的第一线治疗

Sha-Sha Sun1, Xiao-Di Guo1, Wen-Dong Li1

  • 1Department of Oncology, Capital Medical University Affiliated Beijing Ditan Hospital, Beijing 100015, China.

PubMed
概括

用伦瓦提尼布,辛蒂利马布和跨动脉化学栓塞 (TACE) 进行的第一线三重疗法显示,在晚期肝细胞癌 (HCC) 患者中,有希望的生存结果和可管理的副作用.

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K